Flourish Philadelphia

Flourish Philadelphia, formerly known as Keystone Clinical Studies, is a premier clinical research site located in Plymouth Meeting, Pennsylvania, and a key location within the Flourish Research network. Founded in 2003 by Dr. Cherian Verghese, the site specializes in conducting Phase I-IV clinical trials with a primary focus on central nervous system (CNS) disorders, including Alzheimer's disease, Parkinson's disease, and depression. The site has contributed to over 175 clinical trials, leading to the FDA approval of medications for multiple neuro-psychiatric conditions. Following its acquisition and recapitalization by Flourish Research in October 2022, the site continues to leverage its deep clinical expertise, strong community relationships, and commitment to patient diversity to deliver high-quality data for biopharmaceutical sponsors and contract research organizations (CROs).